Medpace Inc.
Medpace is a global full-service CRO providing Phase I-IV core development services for drug, biologic, and device programs. Medpace has extensive experience supporting development programs across multiple hematology-oncology indications, from complex First-In-Human to late stage and post-marketing trials. With global operations, strategic regulatory affairs capabilities, preferred site relationships, and integrated lab services, Medpace has earned a reputation for delivering efficiencies and operational excellence in hematology-oncology clinical research.